SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-326769
Filing Date
2013-08-08
Accepted
2013-08-08 16:01:48
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d558248d10q.htm 10-Q 623767
2 EX-31.1 d558248dex311.htm EX-31.1 5880
3 EX-31.2 d558248dex312.htm EX-31.2 5916
4 EX-32.1 d558248dex321.htm EX-32.1 4095
  Complete submission text file 0001193125-13-326769.txt   6641481

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ziop-20130630.xml EX-101.INS 520866
6 XBRL TAXONOMY EXTENSION SCHEMA ziop-20130630.xsd EX-101.SCH 47221
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20130630_cal.xml EX-101.CAL 40546
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20130630_def.xml EX-101.DEF 255500
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20130630_lab.xml EX-101.LAB 380284
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20130630_pre.xml EX-101.PRE 295671
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 131021798
SIC: 8093 Services-Specialty Outpatient Facilities, NEC